Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: Results of two placebo-controlled trials

Clinical Therapeutics

Volumn 25, Issue 4, 2003, Pages 1056-1073

  Borenstein, David G ^a   Korn, Scott ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Back pain; Cyclobenzaprine; Muscle relaxant; Musculoskeletal spasm

Indexed keywords

ANALGESIC AGENT; CYCLOBENZAPRINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; ANALGESIA; ARTICLE; BACKACHE; CERVICAL SPINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LOW DRUG DOSE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE SPASM; NECK PAIN; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; SEDATION; SKELETAL MUSCLE; SOMNOLENCE; XEROSTOMIA;

EID: 0038746879     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80067-X     Document Type: Article

References (16)

1. Frymoyer JW. Back pain and sciatica. N Engl J Med. 1988;318:291-300.
2. Patel AT, Ogle AA. Diagnosis and management of acute low back pain. Am Fam Physician. 2000;61:1779-1786, 1789-1790.
3. Rubin M. Low back pain: Differentiating mechanical and medical causes. Hosp Med. 1995;31:23-32.
4. Connelly C. Patients with low back pain: How to identify the few who need extra attention. Postgrad Med. 1996;100:143-156.
5. Cailliet R. Low back pain. In: Soft Tissue Pain and Disability. 3rd ed. Philadelphia, Pa: F.A. Davis Company; 1996:101-170.
6. Bosworth T. Special report: The proper use of muscle relaxants in musculoskeletal pain management. Primary Care. 2002;6(Special Edition):1-8.
7. Katz WA, Dube J. Cyclobenzaprine in the treatment of acute muscle spasm: Review of a decade of clinical experience. Clin Ther. 1988;10:216-228.
8. Physicians' Desk Reference. 57th ed. Montvale, NJ: Medical Economics Company; 2003:1897-1898.
9. Nibbelink DW, Strickland SC. Cyclobenzaprine (Flexeril™): Report of a postmarketing surveillance program. Curr Ther Res Clin Exp. 1980;28:894-903.
10. Lines C, Dawson C, Ambrose J, et al. Investigation of the sedative and cognitive effects of cyclobenzaprine compared with diphenhydramine and placebo using a computerized test battery. Drug Dev Res. 1998;27:33-44.
11. Lines C, Traub M, Raskin S, et al. Lack of sedative and cognitive effects of diphenhydramine and cyclobenzaprine in elderly volunteers. J Psychopharmacol. 1997;11:325-329.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958;53:457-481.
13. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics. 1985;41:361-372.
14. Cypress BK. Characteristics of physician visits for back symptoms: A national perspective. Am J Public Health. 1983;73:389-395.
15. Sternbach RA. Survey of pain in the United States: The Nuprin Pain Report. Clin J Pain. 1986;2:49-53.
16. Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am. 1991;22:263-271.